Combination of oncogenic KRASG12D expression and inactivation of tumor suppressor genes Tp53, Cdkn2a and Cdkn2b could induce pancreatic cancer with full penetrance. This evidence concerns the gene CDKN2A and familial pancreatic carcinoma.